glycyrrhizic acid has been researched along with lactic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koga, K; Ohyanagi, K; Shintani, K | 1 |
| Du, GQ; Wang, YM | 1 |
| AlQuadeib, BT; Horrocks, B; Radwan, MA; Šiller, L; Wright, MC | 1 |
3 other study(ies) available for glycyrrhizic acid and lactic acid
| Article | Year |
|---|---|
[Preparation of PLGA microspheres encapsulating highly concentrated glycyrrhizin and the bile elimination of glycyrrhizin after subcutaneous administration in rats].
Topics: Animals; Bile; Capsules; Drug Compounding; Glycyrrhizic Acid; Injections, Subcutaneous; Lactic Acid; Liver; Male; Metabolic Clearance Rate; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Solubility; Water | 2010 |
Glycyrrhizic acid prevents enteritis through reduction of NF‑κB p65 and p38MAPK expression in rat.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Caspase 3; Cyclooxygenase 2; Cytokines; Down-Regulation; Enteritis; Enzyme-Linked Immunosorbent Assay; Glycyrrhizic Acid; Intercellular Adhesion Molecule-1; Lactic Acid; Male; Methotrexate; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Transcription Factor RelA | 2016 |
Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Biological Availability; Biomarkers; Blood Urea Nitrogen; Candida albicans; Creatinine; Drug Carriers; Drug Compounding; Glycyrrhizic Acid; Hemolysis; Kidney Diseases; Lactic Acid; Microbial Sensitivity Tests; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Technology, Pharmaceutical | 2017 |